A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy

التفاصيل البيبلوغرافية
العنوان: A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy
المؤلفون: Q.S-C. Chu, Penny Phillips, Georgia Kollia, Deanne Lathers, Lee M. Krug, Paula M. Fracasso, Natasha B. Leighl, J.R. Jackson, Neal Ready, Charles M. Rudin, P. Basciano, G. Kolaitis, Ben Markman, Daphne Williams
المصدر: Annals of Oncology. 27:vi494
بيانات النشر: Elsevier BV, 2016.
سنة النشر: 2016
مصطلحات موضوعية: 0301 basic medicine, business.industry, medicine.drug_class, Hematology, Monoclonal antibody, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Relapsed refractory, Immunology, Cancer research, Medicine, Fucosyl GM1, Non small cell, business
تدمد: 0923-7534
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::718f805a8ebb7e5d8b97529de186b95dTest
https://doi.org/10.1093/annonc/mdw389.05Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........718f805a8ebb7e5d8b97529de186b95d
قاعدة البيانات: OpenAIRE